Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Lilly to acquire ICOS

Oct. 19, 2006

Canadian clearance for phase I study of PRX-302 in BPH

Oct. 19, 2006

Fresenius to acquire phosphate binder business from Nabi

Oct. 17, 2006

NDA filed for Sanctura XR in overactive bladder

Oct. 16, 2006

Otsuka launching Physuline in Japan

Oct. 16, 2006

New selective dual alpha1A/1D adrenoreceptor antagonists reported by Janssen

Oct. 11, 2006

New alpha1A receptor antagonists for BPH prepared and tested at Ranbaxy

Oct. 5, 2006

Ozarelix improves clinical symptoms of BPH in phase II trial

Oct. 5, 2006

Elocalcitol shows no benefit for pelvic pain in phase IIa study

Oct. 2, 2006

Protox seeks Canadian clearance for phase I study of PRX-302 for BPH

Sep. 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...